CVR number 30358090
Industry 86.2200 Specialist medical practice activities

COLOREKTAL KIRURGISK KLINIK ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.7% 0.7% 0.7% 0.7% 0.7%  
Bankruptcy risk  7.9% 7.4% 3.8% 15.0% 19.5%  
Credit score (0-100)  32 32 49 13 5  
Credit rating  BB BB BBB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  4,978 5,243 6,862 4,268 3,966  
Gross profit  181 255 439 -54.2 157  
EBITDA  156 248 432 -54.2 157  
EBIT  127 240 424 -62.4 149  
Pre-tax profit (PTP)  125.4 238.1 419.1 -70.9 146.6  
Net earnings  96.4 186.1 327.1 -54.9 113.7  
Pre-tax profit without non-rec. items  125 238 419 -70.9 147  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 24.5 16.3 8.2 0.0  
Shareholders equity total  581 767 1,094 213 326  
Interest-bearing liabilities  0.0 0.0 0.2 16.2 16.2  
Balance sheet total (assets)  1,008 859 1,287 311 344  
Net Debt  -524 -151 -600 -2.1 -46.2  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  4,978 5,243 6,862 4,268 3,966  
Net sales growth  -4.4% 5.3% 30.9% -37.8% -7.1%  
Gross profit  181 255 439 -54.2 157  
Gross profit growth  -15.8% 41.1% 72.3% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,008 859 1,287 311 344  
Balance sheet change%  8.7% -14.8% 49.9% -75.8% 10.6%  
Added value  156.0 248.1 432.3 -54.2 156.8  
Added value %  3.1% 4.7% 6.3% -1.3% 4.0%  
Investments  -58 16 -16 -16 -16  
Net sales trend  -2.0 1.0 2.0 -1.0 -2.0  
EBIT trend  4.0 5.0 5.0 -1.0 1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  3.1% 4.7% 6.3% -1.3% 4.0%  
EBIT %  2.5% 4.6% 6.2% -1.5% 3.7%  
EBIT to gross profit (%)  70.2% 94.1% 96.5% 115.1% 94.8%  
Net Earnings %  1.9% 3.5% 4.8% -1.3% 2.9%  
Profit before depreciation and extraordinary items %  2.5% 3.7% 4.9% -1.1% 3.1%  
Pre tax profit less extraordinaries %  2.5% 4.5% 6.1% -1.7% 3.7%  
ROA %  13.1% 25.7% 39.5% -7.8% 45.3%  
ROI %  19.7% 35.6% 45.6% -9.4% 52.0%  
ROE %  15.2% 27.6% 35.1% -8.4% 42.2%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  57.6% 89.3% 85.0% 68.3% 94.8%  
Relative indebtedness %  8.6% 1.8% 2.8% 2.3% 0.5%  
Relative net indebtedness %  -1.9% -1.1% -5.9% 1.9% -1.1%  
Net int. bear. debt to EBITDA, %  -335.5% -60.8% -138.7% 3.8% -29.5%  
Gearing %  0.0% 0.0% 0.0% 7.6% 5.0%  
Net interest  0 0 0 0 0  
Financing costs %  15.0% 0.0% 5,514.8% 104.6% 12.5%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.4 9.1 6.6 3.7 166.8  
Current Ratio  2.4 9.1 6.6 3.7 166.8  
Cash and cash equivalent  523.6 150.9 599.9 18.2 62.4  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  31.2 45.4 34.4 20.0 22.9  
Trade creditors turnover (days)  16.3 3.8 4.4 0.0 0.0  
Current assets / Net sales %  20.2% 15.9% 18.5% 7.1% 8.7%  
Net working capital  581.0 742.5 1,077.8 220.4 342.3  
Net working capital %  11.7% 14.2% 15.7% 5.2% 8.6%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0